The lym Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the lym Hub cannot guarantee the accuracy of translated content. The lym and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The Lymphoma & CLL Hub is an independent medical education platform, sponsored by Beigene, Johnson & Johnson and Roche, and supported through educational grants from Bristol Myers Squibb, Incyte, Lilly, and Pfizer. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View lym content recommended for you
EHA–EBMT 3rd European CAR T-Cell Meeting
Our live event feature page helps you keep up to date with the latest in lymphoma and CLL, fresh from congresses worldwide!
The Lymphoma Hub is happy to be providing live coverage from 3rd European CAR T-cell Meeting, which will be taking place in a virtual format from February 4–6, 2021. Ensure that you stay up to date by following our Twitter and #CART21. Following the meeting, the Lymphoma Hub will be providing articles on key sessions, as well as interviews with leaders in the lymphoma and CLL field — be sure to check our website for the most up-to-date content!
Filter by content: